Literature DB >> 33392088

Solitary Metastasis in the Mediastinal Lymph Node After Radical Nephrectomy for Clear Cell Renal Cell Carcinoma: A Case Report and Literature Review.

Hang Lin1, Heng Zhang1, Yuanda Cheng1,2,3,4, Chunfang Zhang1,2,3,4.   

Abstract

BACKGROUND: Renal cell carcinoma can metastasize to virtually any anatomical site throughout the body, especially the lung, bone, lymph nodes, liver, and brain. However, it is extremely rare for renal cell carcinoma to metastasize solely to the mediastinal lymph node more than 15 years after radical nephrectomy. CASE
PRESENTATION: The case we present here is that of a 50-year-old Chinese male with an isolated posterior mediastinal lymph node metastasis of clear cell renal cell carcinoma 16 years after radical nephrectomy. However, based on imaging examination, the mass was clinically misdiagnosed as Castleman's disease before operation. Following surgical excision of the mass, it was finally judged to be a metastasis from clear cell renal cell carcinoma according to the patient's medical history and immunohistochemical findings. Currently, there is no clinical or radiological finding the recurrence of metastasis after 10 months of follow-up.
CONCLUSION: We report a case of solitary metastasis in the posterior mediastinal lymph node 16 years after radical nephrectomy for clear cell renal cell carcinoma. Given the long disease-free interval between primary renal cell carcinoma to isolated mediastinal lymph node metastasis, it is important to conduct a lifelong regular follow-up, including thoracic computed tomography. In addition, surgical resection remains the best method of treatment for mediastinal lymph node metastases from clear cell renal cell carcinoma if the metastatic lesion is limited.
Copyright © 2020 Lin, Zhang, Cheng and Zhang.

Entities:  

Keywords:  clear cell renal cell carcinoma; posterior mediastinal lymph node; renal cell carcinoma; solitary metastasis; surgical resection

Year:  2020        PMID: 33392088      PMCID: PMC7773822          DOI: 10.3389/fonc.2020.593142

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  47 in total

1.  Enlarged hilar and mediastinal nodes (and especially lower right hilar node enlargement) as a sign of metastasis of a renal tumour.

Authors:  F W Wright
Journal:  Clin Radiol       Date:  1977-07       Impact factor: 2.350

2.  PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin.

Authors:  Ayhan Ozcan; Qihui Zhai; Rehana Javed; Steven S Shen; Donna Coffey; Bhuvaneswari Krishnan; Luan D Truong
Journal:  Arch Pathol Lab Med       Date:  2010-08       Impact factor: 5.534

3.  Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'.

Authors:  D K McGregor; K K Khurana; C Cao; C C Tsao; G Ayala; B Krishnan; J Y Ro; J Lechago; L D Truong
Journal:  Am J Surg Pathol       Date:  2001-12       Impact factor: 6.394

4.  Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience.

Authors:  Ryu Kanzaki; Masahiko Higashiyama; Ayako Fujiwara; Toshiteru Tokunaga; Jun Maeda; Jiro Okami; Kazuo Nishimura; Ken Kodama
Journal:  Eur J Cardiothorac Surg       Date:  2010-06-29       Impact factor: 4.191

Review 5.  Immunohistochemical diagnosis of renal neoplasms.

Authors:  Luan D Truong; Steven S Shen
Journal:  Arch Pathol Lab Med       Date:  2011-01       Impact factor: 5.534

Review 6.  The thoracic duct: structural, functional, and radiologic aspects.

Authors:  A Rosenberger; O Adler; H L Abrams
Journal:  CRC Crit Rev Radiol Sci       Date:  1972-12

7.  Intrathoracic lymph node metastases from extrathoracic neoplasms.

Authors:  T C McLoud; L Kalisher; P Stark; R Greene
Journal:  AJR Am J Roentgenol       Date:  1978-09       Impact factor: 3.959

Review 8.  The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10.

Authors:  Ankur R Sangoi; Jason Karamchandani; Jinah Kim; Reetesh K Pai; Jesse K McKenney
Journal:  Adv Anat Pathol       Date:  2010-11       Impact factor: 3.875

9.  Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.

Authors:  Elizabeth M Genega; Musie Ghebremichael; Robert Najarian; Yineng Fu; Yihong Wang; Pedram Argani; Chiara Grisanzio; Sabina Signoretti
Journal:  Am J Clin Pathol       Date:  2010-12       Impact factor: 2.493

Review 10.  Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT.

Authors:  Blanca Paño Brufau; Carmen Sebastià Cerqueda; Laura Buñesch Villalba; Rafael Salvador Izquierdo; Begoña Mellado González; Carlos Nicolau Molina
Journal:  Radiographics       Date:  2013-10       Impact factor: 5.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.